Microdose Tirzepatide: Why 5 mg Is the Lowest Maintenance Dose in the Trials Even 5 mg of tirzepatide once a week cut body weight by 15% over 72 weeks in a 2,539-person trial of adults with obesity, with 85% of people losing at least 5% of their starting weight
This injection provides a safe and effective alternative for individuals seeking non-invasive solutions for weight loss
The reported mass reflects the complete tirzepatide molecule: the 39-amino-acid peptide backbone with two Aib substitutions, plus the C20 fatty diacid lipid tail, plus the -glutamic acid and two ADO spacer units connecting the lipid to lysine 20, plus the C-terminal serinamide
Do not stop, reduce, or skip blood pressure medication just because your readings improve while taking tirzepatide
Lower calorie intake with the same nutritional needs
At 20 mg/mL, the 2.5 mg dose requires 12.5 units